JAIME L BETANCOURT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health ENGLEWOOD, NJ NPI 1013568153
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health NJ Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,965.85
- Category: General Payments
- Program years: PY2021–2024
- Record count: 152
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,225.24 across 59 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,127.24 | 58 |
| Education | $98.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $368.25 | 6 |
| Daiichi Sankyo Inc. | $220.74 | 6 |
| ABBVIE INC. | $189.40 | 4 |
| Janssen Biotech, Inc. | $179.88 | 5 |
| Pharmacosmos Therapeutics Inc. | $150.00 | 1 |
| Amgen Inc. | $137.56 | 2 |
| Alexion Pharmaceuticals, Inc. | $128.11 | 2 |
| E.R. Squibb & Sons, L.L.C. | $114.06 | 7 |
| Genmab U.S., Inc. | $113.71 | 1 |
| ImmunoGen, Inc. | $108.01 | 1 |
| Merck Sharp & Dohme Corporation | $105.02 | 6 |
| SANOFI-AVENTIS U.S. LLC | $98.00 | 1 |
| Celgene Corporation | $50.28 | 3 |
| GENZYME CORPORATION | $49.79 | 3 |
| PFIZER INC. | $42.96 | 1 |
| TAIHO ONCOLOGY, INC. | $32.96 | 2 |
| GlaxoSmithKline, LLC. | $19.55 | 1 |
| Genentech USA, Inc. | $18.83 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.68 | 1 |
| Aadi Bioscience, Inc. | $16.81 | 1 |
| EMD Serono, Inc. | $16.64 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.54 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.75 | 1 |
| Cumberland Pharmaceuticals, Inc. | $13.71 | 1 |
By program year
Records — PY2024 (59)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.